RYN Stock Analysis: Rayonier | NYSE
REIT - Specialty | NYSE, USA | Market Cap: 6.281m USD | 12M Return: -13.6% | US7549071030 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 63.2M
EPS Trend: 91.8%
Qual. Beats: 0
Rev. Trend: -28.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rayonier Inc. (NYSE: RYN) is a timberland-focused real estate investment trust (REIT) that owns and manages more than four million acres of forestland across the U.S. South and Pacific Northwest. The company operates a diversified land resources business that includes six sawmills, an industrial-grade plywood mill, residential and commercial real estate development, and a rural land sales program. Rayonier emphasizes sustainable forest management, third-party certification, and carbon-related land-based solutions as part of its corporate responsibility framework. Headquartered in Yulee, Florida, the company has been incorporated since 1926 and has been publicly traded since its 1994 IPO.
Timber REITs, the GICS sub-industry in which Rayonier operates, typically generate revenue through a mix of timber harvesting, sawlog and pulpwood sales, land leasing (including hunting and recreational leases), and periodic higher-value land sales such as conservation easements or property conversions to higher uses. Unlike traditional equity REITs that lease buildings, timber REITs rely on biological asset growth, meaning their underlying inventory appreciates naturally over time between harvest cycles. As REITs, these companies are generally required to distribute the majority of their taxable income to shareholders, which often makes them income-oriented holdings.
- Housing starts recovery lifts timber prices and harvest volumes
- Sawmill margins face pressure as lumber prices retreat from highs
- Pacific Northwest wildfire risk threatens timberland harvest capacity
| Net Income: 75.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.78 > 1.0 |
| NWC/Revenue: 43.87% < 20% (prev 61.73%; Δ -17.86% < -1%) |
| CFO/TA 0.05 > 3% & CFO 347.7m > Net Income 75.8m |
| Net Debt (1.49b) to EBITDA (327.4m): 4.56 < 3 |
| Current Ratio: 3.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.2m) vs 12m ago 2.82% < -2% |
| Gross Margin: 17.94% > 18% (prev 39.11%; Δ -21.17% > 0.5%) |
| Asset Turnover: 17.68% > 50% (prev 31.61%; Δ -13.92% > 0%) |
| Interest Coverage Ratio: 1.90 > 6 (EBIT TTM 85.0m / Interest Expense TTM 44.7m) |
| A: 0.06 (Total Current Assets 616.0m - Total Current Liabilities 191.2m) / Total Assets 7.44b |
| B: 0.00 (Retained Earnings 24.9m / Total Assets 7.44b) |
| C: 0.02 (EBIT TTM 85.0m / Avg Total Assets 5.48b) |
| D: 2.39 (Book Value of Equity 5.21b / Total Liabilities 2.18b) |
| Altman-Z'' = 3.00 = A |
| DSRI: 3.0 (Receivables 51.5m/16.3m, Revenue 968.3m/1.11b) |
| GMI: 2.18 (GM 39.11% / 17.94%) |
| AQI: 1.16 (AQ_t 0.83 / AQ_t-1 0.72) |
| SGI: 0.87 (Revenue 968.3m / 1.11b) |
| TATA: -0.04 (NI 75.8m - CFO 347.7m) / TA 7.44b) |
| Beneish M = -0.31 (Cap -4..+1) = D |
As of August 31, 2026, the stock is trading at USD 20.38 with a total of 3,263,149 shares traded. Over the past week, the price has changed by -3.87%, over one month by -7.74%, over three months by -2.28% and over the past year by -13.62%.
Current recommended Stop Loss: 19.70 (which is 3.3% or 1.4 ATR below the current price).
Rayonier has received a consensus analysts rating of 3.57. Therefore, it is recommended to hold RYN.
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 24.8 | 21.8% |
P/E Trailing = 46.2609
P/E Forward = 51.0204
P/S = 4.8772
P/B = 1.2388
P/EG = 23.2357
Revenue TTM = 968.3m USD
EBIT TTM = 85.0m USD
EBITDA TTM = 327.4m USD
Long Term Debt = 1.86b USD (from longTermDebt, last quarter)
Short Term Debt = 10.8m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter) + Leases 13.7m
Net Debt = 1.49b USD (calculated: Debt 1.91b - CCE 411.8m)
Enterprise Value = 7.77b USD (6.28b + Debt 1.91b - CCE 411.8m)
Interest Coverage Ratio = 1.90 (Ebit TTM 85.0m / Interest Expense TTM 44.7m)
EV/FCF = 29.44x (Enterprise Value 7.77b / FCF TTM 264.1m)
FCF Yield = 3.40% (FCF TTM 264.1m / Enterprise Value 7.77b)
FCF Margin = 27.27% (FCF TTM 264.1m / Revenue TTM 968.3m)
Net Margin = 7.83% (Net Income TTM 75.8m / Revenue TTM 968.3m)
Gross Margin = 17.94% ((Revenue TTM 968.3m - Cost of Revenue TTM 794.6m) / Revenue TTM)
Gross Margin QoQ = 19.09% (prev -3.50%)
Tobins Q-Ratio = 1.05 (Enterprise Value 7.77b / Total Assets 7.44b)
Interest Expense / Debt = 2.34% (Interest Expense 44.7m / Debt 1.91b)
Taxrate = 13.12% (2.90m / 22.1m)
NOPAT = 73.8m (EBIT 85.0m * (1 - 13.12%))
Current Ratio = 3.22 (Total Current Assets 616.0m / Total Current Liabilities 191.2m)
Debt / Equity = 0.37 (Debt 1.91b / totalStockholderEquity, last quarter 5.21b)
Debt / EBITDA = 4.56 (Net Debt 1.49b / EBITDA 327.4m)
Debt / FCF = 5.66 (Net Debt 1.49b / FCF TTM 264.1m)
Total Stockholder Equity = 3.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.38% (Net Income 75.8m / Total Assets 7.44b)
RoE = 2.02% (Net Income TTM 75.8m / Total Stockholder Equity 3.76b)
RoCE = 1.51% (EBIT 85.0m / Capital Employed (Equity 3.76b + L.T.Debt 1.86b))
RoIC = 1.02% (NOPAT 73.8m / Invested Capital 7.21b)
WACC = 5.78% (E(6.28b)/V(8.19b) * Re(6.92%) + D(1.91b)/V(8.19b) * Rd(2.34%) * (1-Tc(0.13)))
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.83 | Cagr: 3.11%
[DCF] Terminal Value 77.97% ; FCFF base≈219.4m ; Y1≈251.5m ; Y5≈370.1m
[DCF] Fair Price = 13.55 (EV 5.57b - Net Debt 1.49b = Equity 4.08b / Shares 300.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 91.82 | EPS CAGR: 32.02% | SUE: 0.49 | # QB: 0
Revenue Correlation: -28.34 | Revenue CAGR: -7.55% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.09 | Chg30d=-43.31% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=0.42 | Chg30d=-11.37% | Revisions=-25% | GrowthEPS=-26.8% | GrowthRev=+214.7%
EPS next Year (2027-12-31): EPS=0.61 | Chg30d=-6.75% | Revisions=-40% | GrowthEPS=+47.4% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: -50% (up=0, down=3)